UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 97

Sortiert nach

Development of an autologous canine cancer vaccine system for resectable malignant tumors in dogs

Veterinary immunology and immunopathology, 2016-12, Vol.182, p.95-100

2016

Volltextzugriff (PDF)

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

The Journal of experimental medicine, 1994-07, Vol.180 (1), p.347-352

1994

Volltextzugriff (PDF)

Loss of Functional Beta2-Microglobulin in Metastatic Melanomas From Five Patients Receiving Immunotherapy

JNCI : Journal of the National Cancer Institute, 1996-01, Vol.88 (2), p.100-108

1996

Volltextzugriff (PDF)

Treatment of Patients With Metastatic Melanoma With Autologous Tumor-Infiltrating Lymphocytes and Interleukin 2

JNCI : Journal of the National Cancer Institute, 1994-08, Vol.86 (15), p.1159-1166

1994

Volltextzugriff (PDF)

Clinical and Immune Responses in Advanced Melanoma Patients Immunized With an Anti-Idiotype Antibody Mimicking Disialoganglioside GD2

Journal of clinical oncology, 2000-01, Vol.18 (2), p.376-384

2000

Volltextzugriff (PDF)

Identification of a Human Melanoma Antigen Recognized by Tumor-Infiltrating Lymphocytes Associated with in vivo Tumor Rejection

Proceedings of the National Academy of Sciences - PNAS, 1994-07, Vol.91 (14), p.6458-6462

1994

Volltextzugriff (PDF)

Human Mig chemokine: biochemical and functional characterization

The Journal of experimental medicine, 1995-11, Vol.182 (5), p.1301-1314

1995

Volltextzugriff (PDF)

Growth of tumor‐infiltrating lymphocytes from human solid cancers: Summary of a 5‐year experience

International journal of cancer, 1996-02, Vol.65 (4), p.413-421

1996

Volltextzugriff (PDF)

Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer

The New England journal of medicine, 1987-04, Vol.316 (15), p.898

1987

Volltextzugriff (PDF)

In vitro predictors of therapeutic response in melanoma patients receiving tumor-infiltrating lymphocytes and interleukin-2

Journal of clinical oncology, 1994-07, Vol.12 (7), p.1475-1483

1994

Volltextzugriff (PDF)

Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1

The Journal of immunology (1950), 1995-03, Vol.154 (5), p.2257

1995

Volltextzugriff (PDF)

Recognition of shared melanoma antigens in association with major HLA-A alleles by tumor infiltrating T lymphocytes from 123 patients with melanoma

Journal of immunotherapy, 2000-01, Vol.23 (1), p.17-27

2000

Volltextzugriff (PDF)

On the road to a tumor cell vaccine: 20 years of cellular immunotherapy

Vaccine, 2004-11, Vol.23 (1), p.97-113

2004

Volltextzugriff (PDF)

Enhanced Tumor Growth of Both Primary and Established Human and Murine Tumor Cells in Athymic Mice After Coinjection With Matrigel

JNCI : Journal of the National Cancer Institute, 1991-06, Vol.83 (11), p.769-774

1991

Volltextzugriff (PDF)

Loss of HLA haplotype and B locus down-regulation in melanoma cell lines

The Journal of immunology (1950), 1994-08, Vol.153 (3), p.1225

1994

Volltextzugriff (PDF)

Autologous Dendritic Cell Vaccines for Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2004-07, Vol.22 (14), p.2808-2815

2004

Volltextzugriff (PDF)

Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-infiltrating lymphocytes

The Journal of immunology (1950), 1995-08, Vol.155 (3), p.1343

1995

Volltextzugriff (PDF)

T-Cell Receptor Usage by Melanoma-Specific Clonal and Highly Oligoclonal Tumor-Infiltrating Lymphocyte Lines

Proceedings of the National Academy of Sciences - PNAS, 1994-03, Vol.91 (7), p.2829-2833

1994

Volltextzugriff (PDF)

Adhesion of tumour-infiltrating lymphocytes to endothelium: a phenotypic and functional analysis

British journal of cancer, 1997, Vol.75 (10), p.1421-1431

1997

Volltextzugriff (PDF)

Genetic manipulation of primitive leukemic and normal hematopoietic cells using a novel method of adenovirus-mediated gene transfer

Leukemia, 1999-10, Vol.13 (10), p.1608-1616

1999

Volltextzugriff (PDF)

CD80 expression in an HLA‐A2‐positive human non‐small cell lung cancer cell line enhances tumor‐specific cytotoxicity of HLA‐A2‐positive T cells derived from a normal donor and a patient with non‐small cell lung cancer

International journal of cancer, 1998-12, Vol.78 (6), p.685-694

1998

Volltextzugriff (PDF)

Generation and characterization of non-small-cell lung cancer cell lines and clones for use in the study of immunotherapy

Cancer biotherapy & radiopharmaceuticals, 2010-06, Vol.25 (3), p.269

Yannelli, John R

2010

Volltextzugriff (PDF)

Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition

The Journal of immunology (1950), 1995-01, Vol.154 (2), p.762

1995

Volltextzugriff (PDF)

The preparation of effector cells for use in the adoptive cellular immunotherapy of human cancer

Journal of Immunological Methods, 1991-05, Vol.139 (1), p.1-16

Yannelli, John R.

1991

Volltextzugriff (PDF)

Generation of specific anti-melanoma reactivity by stimulation of human tumor-infiltrating lymphocytes with MAGE-1 synthetic peptide

Cancer Immunology Immunotherapy, 1994-03, Vol.39 (2), p.105-116

1994

Volltextzugriff (PDF)

1 – 25 von 97

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(66)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(73)
Science & Technology
(67)
Life Sciences & Biomedicine
(65)
Biological And Medical Sciences
(42)
Immunotherapy
(34)
Oncology
(32)
Medical Sciences
(31)
Immunology
(27)
Lymphocytes, Tumor-Infiltrating - Immunology
(23)
Melanoma - Immunology
(20)
Tumor Cells, Cultured
(20)
Neoplasms - Therapy
(19)
Female
(18)
Male
(18)
Antineoplastic Agents
(17)
Pharmacology. Drug Treatments
(17)
Adult
(16)
Animals
(16)
Medicine, Research & Experimental
(16)
Research & Experimental Medicine
(16)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Development of an autologous canine cancer vaccine system for resectable malignant tumors in dogs

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

Loss of Functional Beta2-Microglobulin in Metastatic Melanomas From Five Patients Receiving Immunotherapy

Treatment of Patients With Metastatic Melanoma With Autologous Tumor-Infiltrating Lymphocytes and Interleukin 2

Clinical and Immune Responses in Advanced Melanoma Patients Immunized With an Anti-Idiotype Antibody Mimicking Disialoganglioside GD2

Identification of a Human Melanoma Antigen Recognized by Tumor-Infiltrating Lymphocytes Associated with in vivo Tumor Rejection

Human Mig chemokine: biochemical and functional characterization

Growth of tumor‐infiltrating lymphocytes from human solid cancers: Summary of a 5‐year experience

Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer

In vitro predictors of therapeutic response in melanoma patients receiving tumor-infiltrating lymphocytes and interleukin-2

Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1

Recognition of shared melanoma antigens in association with major HLA-A alleles by tumor infiltrating T lymphocytes from 123 patients with melanoma

On the road to a tumor cell vaccine: 20 years of cellular immunotherapy

Enhanced Tumor Growth of Both Primary and Established Human and Murine Tumor Cells in Athymic Mice After Coinjection With Matrigel

Loss of HLA haplotype and B locus down-regulation in melanoma cell lines

Autologous Dendritic Cell Vaccines for Non–Small-Cell Lung Cancer

Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-infiltrating lymphocytes

T-Cell Receptor Usage by Melanoma-Specific Clonal and Highly Oligoclonal Tumor-Infiltrating Lymphocyte Lines

Adhesion of tumour-infiltrating lymphocytes to endothelium: a phenotypic and functional analysis

Genetic manipulation of primitive leukemic and normal hematopoietic cells using a novel method of adenovirus-mediated gene transfer

CD80 expression in an HLA‐A2‐positive human non‐small cell lung cancer cell line enhances tumor‐specific cytotoxicity of HLA‐A2‐positive T cells derived from a normal donor and a patient with non‐small cell lung cancer

Generation and characterization of non-small-cell lung cancer cell lines and clones for use in the study of immunotherapy

Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition

The preparation of effector cells for use in the adoptive cellular immunotherapy of human cancer

Generation of specific anti-melanoma reactivity by stimulation of human tumor-infiltrating lymphocytes with MAGE-1 synthetic peptide

Suchergebnisse filtern